The third terminal Distinction to Han-.docVIP

 PAGE \* MERGEFORMAT 10 ‘The third terminal’ Distinction to Han? Disclaimer: This article starting only from the academic contend that there is no point to any individual. Last December 1, 2006, it was the 56th China National Pharmaceuticals Fair in full swing when, a Johnson amp;amp; Johnson sponsored by the ‘third terminal whether the pharmaceutical industry, Blue Ocean’ were also carried out the focus of debate in full swing. Yeung Sum such high-profile involvement of ‘third terminal’ in controversy, is no more than qualitative ‘community pharmaceutical market in the pharmaceutical industry, Blue Ocean’ in this tone at the same time take the opportunity to enter the community announced that in 2007 the pharmaceutical market. We can see that since 2004 ‘third terminal’ concept has been proposed, around the ‘third terminal’ of the debate has never stopped. And we can clearly see that all of the controversy is nothing but the Chinese pharmaceutical market in order to win the next five years or 10 years of marketing right to speak. So to say, ‘third terminal’ is just a prop, all the competing interests of the pharmaceutical industry interest groups props. We always see from the media, the so-called patent dispute, the standard battle, and now the turn of the pharmaceutical industry. Which competing interests naturally divided into two groups, a so-called ‘third terminal’ support to send, I call it the Southern camp, because a central role in both the South, such as ordinations, CONBA Kuang Shan, gold live medicine Ze Li, from the selection there is, the media mouthpiece for the pharmaceutical sector, a major newspaper, as if accounted for in the debate a bit upper hand; two so-called ‘third terminal’ negative camp, I call it the North camp, because a central role in both is a region in the north, and the background of a joint venture deeper, such as Wang Wei, tetracycline, a Heng, etc., the media can only be covert support to the mouthpiece. But unfortunate